1999
DOI: 10.1253/jcj.63.274
|View full text |Cite
|
Sign up to set email alerts
|

The Time From Anaerobic Threshold (AT) to Respiratory Compensation Point Reflects the Rate of Aerobic and Anaerobic Metabolism After the AT in Chronic Heart Failure Patients

Abstract: hen a subject performs incremental exercising testing, exercise hyperpnea increases toward the end of the exercise. This is due to an increase in acidosis, which is caused by accumulating lactic acid. 1 Lactic acid is produced once the working skeletal muscle cells reach the anaerobic threshold (AT). 2 Usually circulating bicarbonate compensates for this lactic acidosis to begin with. This period is called the isocapnic buffering stage. 3 However, beyond a certain point work intensity becomes so great that lac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
9
0

Year Published

2002
2002
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(10 citation statements)
references
References 13 publications
1
9
0
Order By: Relevance
“…Since the peak VO 2 represents both central and peripheral cardiopulmonary function, and LVEF only represents central cardiac function, the IB phase may imply the endurance performance in CAD patients derived from peripheral effects regardless of LVEF of patients based on our findings. As ∆VO 2 /∆W slope is an indicator of peripheral blood flow [9,23], the significant correlation between the IB phase and ∆VO 2 /∆W slope revealed in our study also suggests that the IB phase is an indicator of the peripheral cardiopulmonary function. Besides, since the IB phase is associated with the well-recognized prognostic factors such as VE/VCO 2 slope, PetCO 2 at AT and peak VO 2 , the IB phase may also infer prognosis of cardiac disease patients.…”
Section: Descriptionsupporting
confidence: 75%
See 1 more Smart Citation
“…Since the peak VO 2 represents both central and peripheral cardiopulmonary function, and LVEF only represents central cardiac function, the IB phase may imply the endurance performance in CAD patients derived from peripheral effects regardless of LVEF of patients based on our findings. As ∆VO 2 /∆W slope is an indicator of peripheral blood flow [9,23], the significant correlation between the IB phase and ∆VO 2 /∆W slope revealed in our study also suggests that the IB phase is an indicator of the peripheral cardiopulmonary function. Besides, since the IB phase is associated with the well-recognized prognostic factors such as VE/VCO 2 slope, PetCO 2 at AT and peak VO 2 , the IB phase may also infer prognosis of cardiac disease patients.…”
Section: Descriptionsupporting
confidence: 75%
“…Masaaki Tanehata et al [9] reported that in chronic heart failure patients, the period of IB phase is closely related to the slope of VO 2 as a function of work rate (∆VO 2 /∆WR), but there is no correlation between the RCP-AT time and the anaerobic threshold. They suggested that the RCP-AT time is an indicator of aerobic metabolism after AT.…”
Section: Descriptionmentioning
confidence: 99%
“…
e can evaluate exercise capacity by oxygen consumption (V • O2), carbon dioxide output (V • CO2) and minute ventilation (V • E), [1][2][3][4] and the slope of the linear regression line between V• CO2 and V • E (SLOPE) is a useful parameter for indicating exercise capacity in chronic heart failure patients. [5][6][7][8][9] Furthermore, SLOPE is an index of ventilatory -perfusion inequality.
…”
mentioning
confidence: 99%
“…e can evaluate exercise capacity by oxygen consumption (V • O2), carbon dioxide output (V • CO2) and minute ventilation (V • E), [1][2][3][4] and the slope of the linear regression line between V…”
mentioning
confidence: 99%
“…Because the symptoms are usually accentuated during exertion, it has been suggested that the functional status of patients with CHF could be reliably indicated by exercise capacity. [26][27][28] However, daily activities do not demand a maximal energy expenditure. Several clinical trials of CHF have included the 'Living With Heart Failure' questionnaire as a measure of QOL.…”
Section: Discussionmentioning
confidence: 99%